June 2026 - NetworkNewsWire

TuesdayJun 30, 2026 12:00 pm

American Fusion(TM) Inc. (AMFN) Files Additional Texatron(TM) Patent Application as Development Advances Toward Testing Milestones

American Fusion(TM) continues development of its 5MW pre-production Texatron(TM) Fusion Engine(TM) and is progressing toward planned testing activities in Texas. Regulatory engagement with the Texas Department of State Health Services remains underway as the company advances certification and licensing requirements. The company is expanding its intellectual property strategy to protect future innovations involving reactor architecture, plasma systems, and commercial deployment methods. Through its wholly owned subsidiary Kepler Fusion Technologies, the company is developing multiple Texatron(TM) system designs aimed at modular energy deployment. The company’s broader commercialization strategy focuses on scalable fusion systems for industrial, commercial, and grid-related energy applications. American…

TuesdayJun 30, 2026 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Ramps Up Operations Team as Montauban Project Advances Toward Production

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising. ESGold Corp., a development-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, recently appointed Pierre-Marc Gagnon, P.Eng., as the Operations Director for the Montauban Project Mr. Gagnon brings operational and technical expertise in drilling, field coordination, technical planning, mine operations and development, and more The appointment comes as continues to advance construction and operational readiness activities at its Montauban Project In his role, Mr. Gagnon will support site execution, operational readiness, contractor coordination, technical planning, and continued development at the…

TuesdayJun 30, 2026 10:30 am

HeartBeam Inc. (NASDAQ: BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital

Advances in digital health, cloud computing and data analytics are making it possible to move beyond episodic monitoring toward a more comprehensive understanding of cardiovascular health. HeartBeam’s proprietary HeartBeam System reflects the company’s mission to make cardiac monitoring accessible beyond the walls of a medical facility. The synthesized 12-lead ECG view provided by the system can help clinicians evaluate rhythm abnormalities and identify rhythm changes that may warrant additional investigation. Cardiac monitoring is evolving beyond the routine detection of abnormal heart rhythms toward a future where patients and physicians receive timely actionable insights that can guide clinical decisions outside of…

TuesdayJun 30, 2026 9:45 am

From Hospitality to Pharma: TechForce Robotics Expanding Its Robotics-as-a-Service Platform into Laboratory Automation

TechForce Robotics has completed the initial deployment of its LIM-E autonomous laboratory support robot at Oncotelic Therapeutics, marking the company's first operational entry into pharmaceutical and laboratory automation. The deployment fulfills Phase 1 objectives under a joint development agreement designed to evaluate robotics and AI-enhanced systems for future GMP-regulated pharmaceutical manufacturing and laboratory workflows. A new strategic alliance with JJ Enterprise adds advanced manufacturing, machine vision, and precision engineering expertise that could support the expansion of high-precision AI-driven applications. Laboratory and pharmaceutical operations increasingly face the same challenge that has accelerated automation across industries from manufacturing to hospitality: how to…

TuesdayJun 30, 2026 9:00 am

Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Advances Manufacturing and Development Efforts as It Pursues a Novel Approach to Hard-to-Treat Cancers

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising. Onco-Innovations is advancing a new class of DNA Damage Response ("DDR") therapies through the development of Polynucleotide Kinase Phosphatase ("PNKP") inhibitors designed to disrupt cancer cells' ability to repair DNA damage. The company recently achieved a key manufacturing milestone with the successful advancement toward kilogram-scale production of the active pharmaceutical ingredient in its lead drug candidate, ONC010. A newly signed Letter of Intent with Nanosoft Polymers is expected to support polymer development, drug delivery optimization and formulation work for the ONC010 program. Cancers frequently exhibit defective repair…

MondayJun 29, 2026 11:15 am

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Prepares to Produce Gold Amid Inflation’s Upward Pressure on Prices

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising. Consumer prices have risen notably during recent months, linked by many to the United States’ involvement in launching the Iran War and the resulting strictures on international energy transports Gold bullion prices have, with expected variations, enjoyed a significant rise since January of last year, and the precious metal is anticipated to continue acting as a long-term “hedge” or “safe haven” against inflationary pressures Near-term gold producer LaFleur Minerals is preparing to restart its recommissioned Beacon Gold Mill and to draw on mineralized material…

MondayJun 29, 2026 10:30 am

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks

Cardio Diagnostics has positioned the science of epigenetics at the center of its diagnostic platform. Looking at an individual person’s epigenetics can provide invaluable insight into the impact of their lifestyle, behavior, and environment. Epigenetics does more than pinpoint a problem, says CEO; it also provides some level of solution. When most people think about their risk for heart disease, they think about family history. Did a parent or grandparent have a heart attack? Is heart disease “in their genes”? It's an understandable assumption, and genetics does play a role in cardiovascular risk. But a growing body of research suggests…

MondayJun 29, 2026 9:45 am

SS Innovations International Inc. (NASDAQ: SSII) Reports Strong Q1 2026 Results with Surgical Robotics Expansion

SS Innovations reported record first-quarter 2026 revenue of $11.1 million, up 116.8% year over year, driven by growing adoption of its SSi Mantra surgical robotic system. The installed base reached 194 SSi Mantra systems across 11 countries, with nearly 9,750 cumulative robotic procedures completed. Regulatory approvals in Sri Lanka, Kenya, Indonesia, and the Philippines, expanded the company's international market access during the quarter. SS Innovations recently completed the world's longest-distance robotic cardiac telesurgery in history, demonstrating the capabilities of its remote surgery platform. The company continues pursuing regulatory clearance in both the United States and Europe while expanding its presence…

MondayJun 29, 2026 9:00 am

Why Market Street Capital Inc. Is ‘One to Watch’

Market Street Capital has evolved from its origins in investor relations into a diversified financial services platform spanning advisory, investment banking, capital raising, restructuring, valuation, and real estate services. The company focuses on established middle-market businesses with enterprise values ranging from $10 million to $1 billion, serving a defined client base that frequently requires sophisticated financial and strategic advisory services. Market Street Capital’s platform combines strategic advisory and transaction execution capabilities, allowing the firm to support clients across multiple stages of the corporate lifecycle. The leadership team brings experience across capital markets, structured finance, mergers and acquisitions, private credit, public…

FridayJun 26, 2026 1:40 pm

What Is a Bank Stress Test and Why Does It Matter?

CNW PocketChange Exploring the concepts, products and innovations influencing currencies, digital assets and global finance. The Federal Reserve's annual stress test evaluates whether the nation's largest banks could continue operating during a severe economic downturn. This year's scenario assumed unemployment rises to 10%, stock prices fall 58%, commercial real estate prices decline 39%, and the economy enters a deep recession. The Fed found that the 32 participating banks could absorb nearly $708 billion in projected losses while maintaining capital above minimum regulatory requirements. June 26, 2026 – via  CurrencyNewsWire -- Every year, the Federal Reserve puts the country's largest banks through a hypothetical financial disaster to determine whether they have enough capital to withstand a…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: June 2026